Your browser doesn't support javascript.
loading
Optimizing dosing of oncology drugs.
Minasian, L; Rosen, O; Auclair, D; Rahman, A; Pazdur, R; Schilsky, R L.
Afiliación
  • Minasian L; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
  • Rosen O; Millennium: The Takeda Oncology Company, Cambridge, Massachusetts, USA.
  • Auclair D; Multiple Myeloma Research Foundation, Norwalk, Connecticut, USA.
  • Rahman A; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Pazdur R; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Schilsky RL; American Society of Clinical Oncology, Alexandria, Virginia, USA.
Clin Pharmacol Ther ; 96(5): 572-9, 2014 Nov.
Article en En | MEDLINE | ID: mdl-25105705

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antineoplásicos Idioma: En Revista: Clin Pharmacol Ther Año: 2014 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antineoplásicos Idioma: En Revista: Clin Pharmacol Ther Año: 2014 Tipo del documento: Article